Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

References

• GoldstrawPCrowleyJChanskyKThe IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumoursJ Thorac Oncol20072870671417762336
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• National Lung Screening Trial Research TeamAberleDRAdamsAMReduced lung-cancer mortality with low-dose computed tomographic screeningN Engl J Med2011365539540921714641
   PubMed Web of Science ®Google Scholar
• HenschkeCIInternational Early Lung Cancer Action Program Investigators. Survival of patients with clinical stage I lung cancer diagnosed by computed tomography screening for lung cancerClin Cancer Res200713174949495017785541
   PubMedGoogle Scholar
• GohaganJKMarcusPMFagerstromRMFinal results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancerLung Cancer200547191515603850
   PubMed Web of Science ®Google Scholar
• BachPBMirkinJNOliverTKBenefits and harms of CT screening for lung cancer: a systematic reviewJAMA2012307222418242922610500
   PubMed Web of Science ®Google Scholar
• de KoningHJMezaRPlevritisSKBenefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceAnn Intern Med2014160531132024379002
   PubMed Web of Science ®Google Scholar
• CroswellJMBakerSGMarcusPMClappJDKramerBSCumulative incidence of false-positive test results in lung cancer screening: a randomized trialAnn Intern Med20101528505512W176W58020404381
   PubMed Web of Science ®Google Scholar
• CrowleyEDi NicolantonioFLoupakisFBardelliALiquid biopsy: monitoring cancer-genetics in the bloodNat Rev Clin Oncol201310847248423836314
   PubMed Web of Science ®Google Scholar
• WanJCMassieCGarcia-CorbachoJLiquid biopsies come of age: towards implementation of circulating tumour DNANat Rev Cancer201717422323828233803
   PubMed Web of Science ®Google Scholar
• Alix-PanabieresCPantelKClinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsyCancer Discov20166547949126969689
   PubMed Web of Science ®Google Scholar
• HaberDAVelculescuVEBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNACancer Discov20144665066124801577
   PubMed Web of Science ®Google Scholar
• BettegowdaCSausenMLearyRJDetection of circulating tumor DNA in early- and late-stage human malignanciesSci Transl Med20146224224ra224
   Web of Science ®Google Scholar
• PlaksVKoopmanCDWerbZCancer. Circulating tumor cellsScience201334161511186118824031008
   PubMed Web of Science ®Google Scholar
• ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
   PubMed Web of Science ®Google Scholar
• Alix-PanabieresCPantelKCirculating tumor cells: liquid biopsy of cancerClin Chem201359111011823014601
   PubMed Web of Science ®Google Scholar
• PantelKAlix-PanabieresCCirculating tumour cells in cancer patients: challenges and perspectivesTrends Mol Med201016939840620667783
   PubMed Web of Science ®Google Scholar
• MegoMManiSACristofanilliMMolecular mechanisms of metastasis in breast cancer clinical applicationsNat Rev Clin Oncol201071269370120956980
   PubMed Web of Science ®Google Scholar
• AllardWJMateraJMillerMCTumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseasesClin Cancer Res200410206897690415501967
   PubMed Web of Science ®Google Scholar
• CristofanilliMBuddGTEllisMJCirculating tumor cells, disease progression, and survival in metastatic breast cancerN Engl J Med2004351878179115317891
   PubMed Web of Science ®Google Scholar
• CoumansFTerstappenLDetection and characterization of circulating tumor cells by the cellSearch approachMethods Mol Biol2015134726327826374323
   PubMedGoogle Scholar
• HanssenAWagnerJGorgesTMCharacterization of different CTC subpopulations in non-small cell lung cancerSci Rep201662801027302574
   PubMedGoogle Scholar
• Bednarz-KnollNAlix-PanabieresCPantelKPlasticity of disseminating cancer cells in patients with epithelial malignanciesCancer Metastasis Rev2012313–467368722733306
   PubMed Web of Science ®Google Scholar
• WongMPCirculating tumor cells as lung cancer biomarkersJ Thorac Dis20124663163423205290
   PubMedGoogle Scholar
• IsobeKHataYKobayashiKClinical significance of circulating tumor cells and free DNA in non-small cell lung cancerAnticancer Res20123283339334422843912
   PubMedGoogle Scholar
• HiroseTMurataYOkiYRelationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancerOncol Res2012202–313113723193919
   PubMed Web of Science ®Google Scholar
• WangJWangKXuJHuangJZhangTPrognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysisPLoS One2013811e7807024223761
   PubMed Web of Science ®Google Scholar
• HanssenALogesSPantelKWikmanHDetection of circulating tumor cells in non-small cell lung cancerFront Oncol2015520726442219
   PubMedGoogle Scholar
• KrebsMGSloaneRPriestLEvaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancerJ Clin Oncol201129121556156321422424
   PubMed Web of Science ®Google Scholar
• HofmanVBonnetaudCIlieMIPreoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarkerClin Cancer Res201117482783521098695
   PubMed Web of Science ®Google Scholar
• MaheswaranSSequistLVNagrathSDetection of mutations in EGFR in circulating lung-cancer cellsN Engl J Med2008359436637718596266
   PubMed Web of Science ®Google Scholar
• PunnooseEAAtwalSLiuWEvaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinibClin Cancer Res20121882391240122492982
   PubMed Web of Science ®Google Scholar
• PunnooseEAAtwalSKSpoerkeJMMolecular biomarker analyses using circulating tumor cellsPLoS One201059e1251720838621
   PubMed Web of Science ®Google Scholar
• KummarSJiJMorganRA phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomasClin Cancer Res20121861726173422307137
   PubMed Web of Science ®Google Scholar
• WangLHPfisterTDParchmentREMonitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cellsClin Cancer Res20101631073108420103672
   PubMedGoogle Scholar
• NiXZhuoMSuZReproducible copy number variation patterns among single circulating tumor cells of lung cancer patientsProc Natl Acad Sci U S A201311052210832108824324171
   PubMed Web of Science ®Google Scholar
• JahrSHentzeHEnglischSDNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cellsCancer Res20016141659166511245480
   PubMed Web of Science ®Google Scholar
• PathakAKBhutaniMKumarSMohanAGuleriaRCirculating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic toolClin Chem200652101833184216423903
   PubMed Web of Science ®Google Scholar
• LuiYYChikKWChiuRWHoCYLamCWLoYMPredominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantationClin Chem200248342142711861434
   PubMed Web of Science ®Google Scholar
• El MessaoudiSRoletFMouliereFThierryARCirculating cell free DNA: preanalytical considerationsClin Chim Acta201342422223023727028
   PubMed Web of Science ®Google Scholar
• WartonKLinVNavinTMethylation-capture and next-generation sequencing of free circulating DNA from human plasmaBMC Genomics20141547624929644
   PubMedGoogle Scholar
• SchwarzenbachHAlix-PanabieresCMullerICell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancerClin Cancer Res20091531032103819188176
   PubMed Web of Science ®Google Scholar
• ShawJABrownJCoombesRCCirculating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancerBiomark Med201151879121319970
   PubMedGoogle Scholar
• SchwarzenbachHHoonDSPantelKCell-free nucleic acids as biomarkers in cancer patientsNat Rev Cancer201111642643721562580
   PubMed Web of Science ®Google Scholar
• ThakurBKZhangHBeckerADouble-stranded DNA in exosomes: a novel biomarker in cancer detectionCell Res201424676676924710597
   PubMed Web of Science ®Google Scholar
• RamirezJLRosellRTaronM14–3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer GroupJ Clin Oncol200523369105911216361617
   PubMedGoogle Scholar
• BalgkouranidouIChimonidouMMilakiGSOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancerClin Chem Lab Med20165481385139326741346
   PubMed Web of Science ®Google Scholar
• KonecnyMMarkusJWaczulikovaIThe value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disordersNeoplasma201663224625326774146
   PubMed Web of Science ®Google Scholar
• ZhangYWangRSongHMethylation of multiple genes as a candidate biomarker in non-small cell lung cancerCancer Lett20113031212821255913
   PubMed Web of Science ®Google Scholar
• DiehlFSchmidtKChotiMACirculating mutant DNA to assess tumor dynamicsNat Med200814998599018670422
   PubMed Web of Science ®Google Scholar
• ChanKCJiangPZhengYWCancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencingClin Chem201359121122423065472
   PubMed Web of Science ®Google Scholar
• ChengFSuLQianCCirculating tumor DNA: a promising biomarker in the liquid biopsy of cancerOncotarget2016730488324884127223063
   PubMedGoogle Scholar
• GaoYZhangKXiHDiagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysisOncotarget2017846330634028009985
   PubMed Web of Science ®Google Scholar
• MaoCYuanJQYangZYFuXHWuXYTangJLBlood as a substitute for tumor tissue in detecting EGFR mutations for guiding EGFR TKIs treatment of nonsmall cell lung cancer: a systematic review and meta-analysisMedicine (Baltimore)20159421e77526020382
   PubMed Web of Science ®Google Scholar
• FanGZhangKDingJLiJPrognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysisOncotarget2017820339223393228430611
   PubMedGoogle Scholar
• KlcoJMMillerCAGriffithMAssociation between mutation clearance after induction therapy and outcomes in acute myeloid leukemiaJAMA2015314881182226305651
   PubMed Web of Science ®Google Scholar
• PecuchetNZontaEDidelotABase-position error rate analysis of next-generation sequencing applied to circulating tumor DNA in non-small cell lung cancer: A Prospective StudyPLoS Med20161312e100219928027313
   PubMed Web of Science ®Google Scholar
• FujiwaraKFujimotoNTabataMIdentification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancerClin Cancer Res20051131219122515709192
   PubMed Web of Science ®Google Scholar
• ShamesDSGirardLGaoBA genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesPLoS Med2006312e48617194187
   PubMedGoogle Scholar
• ShivapurkarNGazdarAFDNA methylation based biomarkers in non-invasive cancer screeningCurr Mol Med201010212313220196733
   PubMed Web of Science ®Google Scholar
• KneipCSchmidtBSeegebarthASHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaJ Thorac Oncol20116101632163821694641
   PubMed Web of Science ®Google Scholar
• PowrozekTKrawczykPNicosMKuznar-KaminskaBBatura-GabryelHMilanowskiJMethylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patientsClin Transl Oncol201618439840426311076
   PubMed Web of Science ®Google Scholar
• PowrozekTKrawczykPKucharczykTMilanowskiJSeptin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary reportMed Oncol201431491724633736
   PubMed Web of Science ®Google Scholar
• PonomaryovaAARykovaEYCherdyntsevaNVPotentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patientsLung Cancer201381339740323806794
   PubMed Web of Science ®Google Scholar
• BalgkouranidouIChimonidouMMilakiGBreast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancerBr J Cancer201411082054206224642624
   PubMed Web of Science ®Google Scholar
• WangHZhangBChenDReal-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancerClin Epigenetics2015711926550041
   PubMed Web of Science ®Google Scholar
• SchmidtBBeyerJDietrichDBorkILiebenbergVFleischhackerMQuantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patientsPLoS One2015102e011819525675432
   PubMed Web of Science ®Google Scholar
• SalazarFMolinaMASanchez-RoncoMFirst-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small cell lung cancer patientsLung Cancer2011721849120705357
   PubMed Web of Science ®Google Scholar
• MitchellPSParkinRKKrohEMCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci U S A200810530105131051818663219
   PubMed Web of Science ®Google Scholar
• ChenXBaYMaLCharacterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Res20081810997100618766170
   PubMed Web of Science ®Google Scholar
• FanLQiHTengJIdentification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancerTumour Biol20163767777778426695145
   PubMedGoogle Scholar
• VoliniaSCalinGALiuCGA microRNA expression signature of human solid tumors defines cancer gene targetsProc Natl Acad Sci U S A200610372257226116461460
   PubMed Web of Science ®Google Scholar
• BoeriMVerriCConteDMicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerProc Natl Acad Sci U S A201110893713371821300873
   PubMed Web of Science ®Google Scholar
• ShenJToddNWZhangHPlasma microRNAs as potential biomarkers for non-small-cell lung cancerLab Invest201191457958721116241
   PubMed Web of Science ®Google Scholar
• BianchiFNicassioFMarziMA serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancerEMBO Mol Med20113849550321744498
   PubMed Web of Science ®Google Scholar
• MarkouASourvinouIVorkasPAYousefGMLianidouEClinical evaluation of microRNA expression profiling in non small cell lung cancerLung Cancer201381338839623756108
   PubMed Web of Science ®Google Scholar
• MaJLiuSWangYMicroRNA-21 and multiple myeloma: small molecule and big functionMed Oncol20143189424981236
   PubMedGoogle Scholar
• YangMShenHQiuCHigh expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancerEur J Cancer201349360461523099007
   PubMed Web of Science ®Google Scholar
• TrangPWigginsJFDaigeCLSystemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in miceMol Ther20111961116112221427705
   PubMed Web of Science ®Google Scholar
• TheryCOstrowskiMSeguraEMembrane vesicles as conveyors of immune responsesNat Rev Immunol20099858159319498381
   PubMed Web of Science ®Google Scholar
• HuotariJHeleniusAEndosome maturationEMBO J201130173481350021878991
   PubMed Web of Science ®Google Scholar
• van der PolEBoingANHarrisonPSturkANieuwlandRClassification, functions, and clinical relevance of extracellular vesiclesPharmacol Rev201264367670522722893
   PubMed Web of Science ®Google Scholar
• BobrieAColomboMRaposoGTheryCExosome secretion: molecular mechanisms and roles in immune responsesTraffic201112121659166821645191
   PubMed Web of Science ®Google Scholar
• ReclusaPSireraRAraujoAExosomes genetic cargo in lung cancer: a truly Pandora’s boxTransl Lung Cancer Res20165548349127826529
   PubMedGoogle Scholar
• KahlertCMeloSAProtopopovAIdentification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancerJ Biol Chem201428973869387524398677
   PubMed Web of Science ®Google Scholar
• AllensonKCastilloJSan LucasFAHigh prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patientsAnn Oncol201728474174728104621
   PubMed Web of Science ®Google Scholar
• HaoYXLiYMYeMKRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese populationOncol Lett20171353608361628521461
   PubMedGoogle Scholar
• ReclusaPGiallombardoMCastigliaMP2.06: Exosomal miRNA analysis in non-small cell lung cancer: new liquid biomarker?: track: biology and pathogenesisJ Thorac Oncol20161110SS219S22027676543
   PubMedGoogle Scholar
• GiallombardoMChacartegui BorrasJCastigliaMExosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients’ plasma through qPCR: a feasible liquid biopsy toolJ Vis Exp2016111
   Google Scholar
• YuHAPerezLChangQA phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinibJ Thorac Oncol201712110210927613527
   PubMed Web of Science ®Google Scholar
• JakobsenKRPaulsenBSBaekRVarmingKSorensenBSJorgensenMMExosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinomaJ Extracell Vesicles201542665925735706
   PubMed Web of Science ®Google Scholar
• Sandfeld-PaulsenBJakobsenKRBaekRExosomal proteins as diagnostic biomarkers in lung cancerJ Thorac Oncol201611101701171027343445
   PubMed Web of Science ®Google Scholar
• MolinaRFilellaXAugeJMTumor markers (CEA, CA 125, CYFRA 21–1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factorsTumour Biol200324420921814654716
   PubMedGoogle Scholar
• BarlesiFGimenezCTorreJPPrognostic value of combination of Cyfra 21–1, CEA and NSE in patients with advanced non-small cell lung cancerRespir Med200498435736215080079
   PubMed Web of Science ®Google Scholar